CustomSurg, provider of data-driven, end-to-end solutions for faster surgeries on complex bone fractures, has obtained an undisclosed amount in its funding round led by US East Coast Fund CHMBR Partners LLC. The funds will be used to accelerate the FDA regulatory application process and launch the first-in-human study and establish its presence in the US market.
